XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 151 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $20,496,000 | +88627.3% | 600,000 | 0.0% | 1.09% | +1.9% |
Q2 2023 | $23,100 | +7.6% | 600,000 | 0.0% | 1.07% | +1.5% |
Q1 2023 | $21,474 | -99.9% | 600,000 | 0.0% | 1.06% | -15.4% |
Q4 2022 | $23,658,000 | +9.2% | 600,000 | 0.0% | 1.25% | +2.4% |
Q3 2022 | $21,660,000 | +18.7% | 600,000 | 0.0% | 1.22% | +5.4% |
Q2 2022 | $18,252,000 | -0.5% | 600,000 | 0.0% | 1.16% | +22.6% |
Q1 2022 | $18,342,000 | -2.1% | 600,000 | 0.0% | 0.94% | +29.5% |
Q4 2021 | $18,744,000 | +43.1% | 600,000 | -30.0% | 0.73% | +59.3% |
Q3 2021 | $13,095,000 | -17.9% | 857,000 | 0.0% | 0.46% | -18.8% |
Q2 2021 | $15,957,000 | +140.2% | 857,000 | +42.8% | 0.56% | +144.8% |
Q3 2020 | $6,642,000 | -11.7% | 600,000 | 0.0% | 0.23% | -30.5% |
Q2 2020 | $7,524,000 | +10.6% | 600,000 | 0.0% | 0.33% | -28.7% |
Q1 2020 | $6,804,000 | +71.8% | 600,000 | +100.0% | 0.46% | +5.7% |
Q3 2018 | $3,960,000 | – | 300,000 | – | 0.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |